New HIV prevention drug lenacapavir shows 100% efficacy

ScienceAlert July 10, 2024, 08:00 AM UTC

Summary: A new HIV prevention drug, lenacapavir, showed 100% efficacy in a clinical trial in South Africa and Uganda. The trial included 5,000 young women, with none of the 2,134 women who received lenacapavir contracting HIV. The drug, administered twice yearly, offers hope for highly effective HIV prevention. The trial's success may lead to global adoption pending regulatory approvals and pricing considerations.

Full article

Article metrics
Significance6.3
Scale7.0
Magnitude8.0
Novelty9.0
Actionability6.0
Immediacy7.0
Positivity9.0
Probability8.0
Credibility7.8

Timeline:

  1. [4.4]
    Biannual lenacapavir injection 100% effective in preventing HIV (News Karnataka)
    1d
    Source
  2. [5.1]
    UNAIDS urges global access to new HIV drug Lenacapavir (Marketscreener.com)
    4d

  3. [4.6]
    Biannual Lenacapavir injection 100% effective against HIV (WION)
    7d
    Source
  4. [5.8]
    Lenacapavir injection offers 100% HIV protection to young women (Hindustan Times)
    8d

  5. [5.2]
    HIV prevention drug lenacapavir safe and effective in trial (The East African)
    9d

  6. [6.1]
    HIV prevention injection successful in South Africa trial (AllAfrica - Top Africa News)
    14d